Download our app Order a test
News

Promising new immunotherapy for colorectal cancer patients

Patients with advanced colorectal cancer can benefit from treatment with advanced immunotherapy, known as immune checkpoint inhibitor PD-1/PD-L1, scientists have discovered. The findings provide new hope for colorectal cancer patients and more broadly demonstrate the incredible potential for immunotherapies to extend life and treat all forms of cancer. If chemotherapy fails, patients with microsatellite stable […]

Read more

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.

Find out more